Complementary UV-MALDI and IR-MALDESI Imaging Expand Metabolomic Coverage in the 6-OHDA Rat Model of Parkinson’s Disease
Journal of the American Society for Mass Spectrometry · 2026-08-05 · 37 (8) · 1744-1753
DOI: 10.1021/jasms.5c00424 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, published online on 2026-07-17. Written by Mary F Wang and 6 co-authors. Institution: Biological Imaging Laboratory for Disease and Exposure Research (BILDER), Department of Chemistry, North Carolina State University, Raleigh, North Ca…. Major MEDLINE topics: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Metabolomics, Parkinson Disease. Cited 1 times so far (Crossref); 65 references. Funded by: NIGMS NIH HHS, North Carolina State University, Vetenskapsr?det.
Abstract (original language)
In this study, we demonstrate the complementary strengths of FMP-10 (4-(Anthracen-9-yl)-2-fluoro-1-methylpyridin-1-ium iodide) on-tissue derivatization with UV-MALDI MSI and IR-MALDESI MSI without derivatization for small molecule analysis. These MSI approaches were applied to the striatum of rats administered 6-OHDA to induce dopaminergic neurodegeneration, modeling Parkinson’s disease. UV-MALDI MSI with FMP-10 derivatization enhanced the detection of dopaminergic and serotonergic metabolites, revealing clear lesion-related effects. IR-MALDESI MSI, in turn, expanded the molecular coverage by detecting several hundred additional small molecules, including neurotransmitters, amino acids, and lipids. The complementary application of these ionization strategies broadened metabolomic coverage, highlighting their potential for broader disease-related studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Biological Imaging Laboratory for Disease and Exposure Research (BILDER), Department of Chemistry, North Carolina State University, Raleigh, North Carolina27695, United States.
- Department of Pharmaceutical Biosciences, Spatial Mass Spectrometry, Science for Life Laboratory, Uppsala Universitet, Uppsala75124, Sweden.
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm171 77, Sweden.
ORCID profiles: Mary F Wang, Reza Shariatgorji, Per E Andrén, David C Muddiman
Funding
- NIGMS NIH HHS
- North Carolina State University
- Vetenskapsr?det
- Science for Life Laboratory
- Swedish Brain Foundation
- National Institute of General Medical Sciences
Cite
APA
Wang, M. F., Shariatgorji, R., Nilsson, A., Kaya, I., Svenningsson, P., Andrén, P. E., & Muddiman, D. C. (2026). Complementary UV-MALDI and IR-MALDESI Imaging Expand Metabolomic Coverage in the 6-OHDA Rat Model of Parkinson’s Disease. Journal of the American Society for Mass Spectrometry, 37(8), 1744-1753. https://doi.org/10.1021/jasms.5c00424
Vancouver
Wang MF, Shariatgorji R, Nilsson A, Kaya I, Svenningsson P, Andrén PE, et al. Complementary UV-MALDI and IR-MALDESI Imaging Expand Metabolomic Coverage in the 6-OHDA Rat Model of Parkinson’s Disease. Journal of the American Society for Mass Spectrometry. 2026;37(8):1744-1753. doi:10.1021/jasms.5c00424
BibTeX
@article{Wang2026,
author = {Wang, Mary F and Shariatgorji, Reza and Nilsson, Anna and Kaya, Ibrahim and Svenningsson, Per and Andrén, Per E and Muddiman, David C},
title = {Complementary UV-MALDI and IR-MALDESI Imaging Expand Metabolomic Coverage in the 6-OHDA Rat Model of Parkinson’s Disease},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2026},
volume = {37},
number = {8},
pages = {1744--1753},
doi = {10.1021/jasms.5c00424}
}
EUVIMED